Earnings

DSW (DSW) Shares Down Nearly 8% Despite Strong Sales Growth

Posted on 03/16/10 at 12:18pm
Swinging to a 4th quarter profit and having strong sales growth didn't keep shares of DSW Inc. (NYSE: DSW) from falling after the company reported earnings that missed analyst target estimates. DSW Inc. reported a 4th quarter profit of $13.4 million, or 30 cents per share, compared to a loss of $7.5 million, or 14 cents per share, a year earlier.
Click here to read the rest of the article
Posted in

China Fire & Security Group (CFSG) Shares Fall 9%

Posted on 03/16/10 at 11:38am
Shares of China Fire & Security Group, Inc. (Nasdaq: CFSG) are down 9%, after the company released an earnings report that failed to meet Wall Street expectations.
Click here to read the rest of the article
Posted in

Goldman Downgrades TEVA On Valuation

Posted on 03/16/10 at 11:13am
Analysts at Goldman Sachs downgrade Teva Pharmaceutical (NASDAQ: TEVA) from "conviction buy" to "buy." The target price for TEVA is set to $67. According to Goldman Sachs, the downgrade in the rating is based on valuation. TEVA’s shares lost 0.96% to $60.40. More Analyst Ratings here
Click here to read the rest of the article
Posted in

CYH Upgraded To Neutral

Posted on 03/16/10 at 11:10am
Analysts at Goldman Sachs upgrade Community Health (NYSE: CYH) from "conviction sell" to "neutral." CYH’s shares gained 0.48% to trade at $37.91. More Analyst Ratings here
Click here to read the rest of the article
Posted in

BSX Downgraded To Conviction Sell At Goldman

Posted on 03/16/10 at 11:05am
Analysts at Goldman Sachs downgrade Boston Scientific (NYSE: BSX) from "neutral" to "conviction sell." The target price for BSX is set to $6. BSX’ gained 1.47% to trade at $6.90. More Analyst Ratings here
Click here to read the rest of the article
Posted in

Goldman Downgrades UNH To Buy

Posted on 03/16/10 at 11:03am
Analysts at Goldman Sachs downgrade UnitedHealth (NYSE: UNH) from "conviction buy" to "buy." UNH’s shares dipped 1.01% to trade at $32.20. More Analyst Ratings here
Click here to read the rest of the article
Posted in

ONXX Upgraded To Buy At Goldman

Posted on 03/16/10 at 11:01am
Analysts at Goldman Sachs upgrade Onyx Pharma (NASDAQ: ONYX) from "neutral" to "buy." The target price for ONXX has been raised from $34 to $37. ONXX’s shares closed at $31.50 yesterday. More Analyst Ratings here
Click here to read the rest of the article
Posted in

ALXN Upgraded To Conviction Buy At Goldman

Posted on 03/16/10 at 10:59am
Analysts at Goldman Sachs upgrade Alexion Pharma (NASDAQ: ALXN) from "buy" to "conviction buy." The target price for ALXN has been raised from $57 to $62. ALXN’s shares closed at $52.85 yesterday. More Analyst Ratings here
Click here to read the rest of the article
Posted in

Goldman Upgrades STJ To Sell

Posted on 03/16/10 at 10:57am
Analysts at Goldman Sachs upgrade St Jude Medical (NYSE: STJ) from "conviction sell" to "sell." STJ’s shares closed at $40.56 yesterday. More Analyst Ratings here
Click here to read the rest of the article
Posted in

SAI Initiated With Hold

Posted on 03/16/10 at 10:55am
Analysts at CK Cooper initiate coverage of SAIC Inc (NYSE: SAI) with a "hold" rating. SAI’s shares closed at $19.35 yesterday. More Analyst Ratings here
Click here to read the rest of the article
Posted in